Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications (Q34080418)

30 July 2017

1 reference

title

Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications (English)

1 reference

30 July 2017

Aubard Y

1

1 reference

PubMed ID

11074137

30 July 2017

Darodes N

series ordinal

2

1 reference

PubMed ID

11074137

30 July 2017

Cantaloube M

series ordinal

3

1 reference

30 July 2017

1 December 2000

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

30 July 2017

1 reference

30 July 2017

93

1 reference

30 July 2017

157-165

1 reference

30 July 2017

2

1 reference

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Changes in homocysteine levels during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Clinical chemistry and molecular biology of homocysteine metabolism: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Plasma homocyst(e)ine levels in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

The case that hyperhomocysteinemia is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine in cerebral macroangiography and microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Maternal and fetal levels of methionine and homocysteine in early human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Preeclampsia: an endothelial cell disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Is oxidative stress the link in the two-stage model of pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Elevated homocyst(e)ine levels with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocysteinemia: a risk factor for placental abruption or infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Open or closed? A world of difference: a history of homocysteine research.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine metabolism in pregnancies complicated by neural-tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Presence of the French Canadian deletion in a French patient with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Periconceptional folic acid containing multivitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Assessment of homocysteine status

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Homocysteine--a pathophysiological cornerstone in obstetrical and gynaecological disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900282-7

7 January 2021

10.1016/S0301-2115(00)00282-7

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11074137